ProfileGDS4284 / 1570391_at
TitleChronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood
OrganismHomo sapiens


control 0.2 mg/kg 1 mg/kg 2 mg/kg 4 mg/kg 6 mg/kg pre-treatment 24 hrs 4 wks 24 hrs 4 wks 24 hrs 4 wks 4 hrs 24 hrs 4 wks 4 hrs 24 hrs 4 wks 401 402 403 404 411 422 424 425 427 428 441 443 444 448 449 450 451 452 401 402 411 402 411 422 403 424 427 403 424 427 428 449 450 425 428 443 444 449 450 425 428 443 449 450 404 448 451 452 404 441 448 451 452 451 452 GSM687644 GSM687648 GSM687653 GSM687658 GSM687663 GSM687668 GSM687673 GSM687678 GSM687683 GSM687688 GSM687695 GSM687699 GSM687704 GSM687707 GSM687712 GSM687719 GSM687724 GSM687728 GSM687646 GSM687649 GSM687665 GSM687651 GSM687667 GSM687670 GSM687671 GSM687654 GSM687675 GSM687685 GSM687656 GSM687677 GSM687687 GSM687692 GSM687716 GSM687722 GSM687680 GSM687690 GSM687700 GSM687705 GSM687714 GSM687721 GSM687682 GSM687694 GSM687702 GSM687718 GSM687723 GSM687661 GSM687710 GSM687726 GSM687730 GSM687660 GSM687697 GSM687709 GSM687725 GSM687729 GSM687727 GSM687731 1% 0% 1% 2% 3% 4% 1% 0% 3% 0% 3% 0% 10% 1% 1% 2% 4% 1% 1% 2% 5% 1% 1% 2% 6% 0% 1% 6% 6% 1% 3% 1% 3% 1% 0% 7% 9% 13% 0% 4% 2% 0% 0% 1% 3% 1% 0% 1% 30% 2% 4% 14% 5% 1% 1% 4% sort by dose sort by time sort by individual Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM687644Patient 401 control2.603721
GSM687648Patient 402 control1.467230
GSM687653Patient 403 control2.47431
GSM687658Patient 404 control6.155012
GSM687663Patient 411 control7.428133
GSM687668Patient 422 control7.71854
GSM687673Patient 424 control4.785941
GSM687678Patient 425 control1.836290
GSM687683Patient 427 control7.906723
GSM687688Patient 428 control1.913830
GSM687695Patient 441 control15.81853
GSM687699Patient 443 control2.758380
GSM687704Patient 444 control16.233910
GSM687707Patient 448 control4.335921
GSM687712Patient 449 control4.958361
GSM687719Patient 450 control8.230882
GSM687724Patient 451 control10.77464
GSM687728Patient 452 control2.952041
GSM687646Patient 401 treated 24h2.936041
GSM687649Patient 402 treated 24h4.881452
GSM687665Patient 411 treated 24h10.95015
GSM687651Patient 402 treated 4 weeks4.497761
GSM687667Patient 411 treated 4 weeks5.444331
GSM687670Patient 422 treated 24h6.281252
GSM687671Patient 422 treated 4 weeks10.17566
GSM687654Patient 403 treated 24h1.808650
GSM687675Patient 424 treated 24h5.225361
GSM687685Patient 427 treated 24h10.45876
GSM687656Patient 403 treated 4 weeks9.091156
GSM687677Patient 424 treated 4 weeks2.36971
GSM687687Patient 427 treated 4 weeks6.327683
GSM687692Patient 428 treated 4h2.938241
GSM687716Patient 449 treated 4h8.117663
GSM687722Patient 450 treated 4h4.782651
GSM687680Patient 425 treated 24h2.248320
GSM687690Patient 428 treated 24h12.16577
GSM687700Patient 443 treated 24h26.7889
GSM687705Patient 444 treated 24h20.984813
GSM687714Patient 449 treated 24h1.600990
GSM687721Patient 450 treated 24h10.774
GSM687682Patient 425 treated 4 weeks5.082622
GSM687694Patient 428 treated 4 weeks1.554050
GSM687702Patient 443 treated 4 weeks1.816840
GSM687718Patient 449 treated 4 weeks2.878161
GSM687723Patient 450 treated 4 weeks7.90183
GSM687661Patient 404 treated 4h3.786661
GSM687710Patient 448 treated 4h2.21040
GSM687726Patient 451 treated 4h5.152361
GSM687730Patient 452 treated 4h168.63230
GSM687660Patient 404 treated 24h9.642042
GSM687697Patient 441 treated 24h12.69814
GSM687709Patient 448 treated 24h26.87814
GSM687725Patient 451 treated 24h13.04335
GSM687729Patient 452 treated 24h6.752761
GSM687727Patient 451 treated 4 weeks3.800541
GSM687731Patient 452 treated 4 weeks9.419034